Resting natural killer cell homeostasis relies on tryptophan/NAD+ metabolism and HIF‐1α
EMBO Reports · 05.06.2023 · 24 (6)
DOI: 10.15252/embr.202256156 ↗Kurz gefasst
Fachartikel in der Zeitschrift EMBO Reports, online erschienen am 29.03.2023. Verfasst von Abigaelle Pelletier und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Anatomy, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Tryptophan, NAD. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, SNF | Swiss National Centre of Competence in Research Kidney Control of Homeostasis, Swiss Cancer Foundation.
Abstract (Originalsprache)
Natural killer (NK) cells are forced to cope with different oxygen environments even under resting conditions. The adaptation to low oxygen is regulated by oxygen‐sensitive transcription factors, the hypoxia‐inducible factors (HIFs). The function of HIFs for NK cell activation and metabolic rewiring remains controversial. Activated NK cells are predominantly glycolytic, but the metabolic programs that ensure the maintenance of resting NK cells are enigmatic. By combining in situ metabolomic and transcriptomic analyses in resting murine NK cells, our study defines HIF‐1α as a regulator of tryptophan metabolism and cellular nicotinamide adenine dinucleotide (NAD + ) levels. The HIF‐1α/NAD + axis prevents ROS production during oxidative phosphorylation (OxPhos) and thereby blocks DNA damage and NK cell apoptosis under steady‐state conditions. In contrast, in activated NK cells under hypoxia, HIF‐1α is required for glycolysis, and forced HIF‐1α expression boosts glycolysis and NK cell performance in vitro and in vivo . Our data highlight two distinct pathways by which HIF‐1α interferes with NK cell metabolism. While HIF‐1α‐driven glycolysis is essential for NK cell activation, resting NK cell homeostasis relies on HIF‐1α‐dependent tryptophan/NAD + metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Anatomy, University of Zurich, Zurich, Switzerland.
- Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.
- Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université UM2, Inserm, U1104, CNRS UMR7280, Marseille, France.
- Institut für Physiologie, Universitätsklinikum Essen, Universität Duisburg-Essen, Essen, Germany.
- Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna, Austria.
- University of Innsbruck, InnSbruck, Austria.
ORCID-Profile: Eric Nelius, Abdiel Alvarado-Diaz, Dagmar Gotthardt, Christian Stockmann
Förderung
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- SNF | Swiss National Centre of Competence in Research Kidney Control of Homeostasis
- Swiss Cancer Foundation
- Swiss Cancer Research Foundation
- University of Zurich
Zitieren
APA
Pelletier, A., Nelius, E., Fan, Z., Khatchatourova, E., Alvarado-Diaz, A., He, J., Krzywinska, E., Sobecki, M., Nagarajan, S., Kerdiles, Y., Fandrey, J., Gotthardt, D., Sexl, V., de Bock, K., & Stockmann, C. (2023). Resting natural killer cell homeostasis relies on tryptophan/NAD+ metabolism and HIF‐1α. EMBO Reports, 24(6). https://doi.org/10.15252/embr.202256156
Vancouver
Pelletier A, Nelius E, Fan Z, Khatchatourova E, Alvarado-Diaz A, He J, et al. Resting natural killer cell homeostasis relies on tryptophan/NAD+ metabolism and HIF‐1α. EMBO Reports. 2023;24(6). doi:10.15252/embr.202256156
BibTeX
@article{Pelletier2023,
author = {Pelletier, Abigaelle and Nelius, Eric and Fan, Zheng and Khatchatourova, Ekaterina and Alvarado-Diaz, Abdiel and He, Jingyi and Krzywinska, Ewelina and Sobecki, Michal and Nagarajan, Shunmugam and Kerdiles, Yann and Fandrey, Joachim and Gotthardt, Dagmar and Sexl, Veronika and de Bock, Katrien and Stockmann, Christian},
title = {Resting natural killer cell homeostasis relies on tryptophan/NAD+ metabolism and HIF‐1α},
journal = {EMBO Reports},
year = {2023},
volume = {24},
number = {6},
doi = {10.15252/embr.202256156}
}
EUVIMED